MND

3515's picture

CHMP2B Mutations are Rare in French Families with Frontotemporal Lobar Degeneration.‎

Journal Title, Volume, Page: 
J Neurol, 257:2032–2036
Year of Publication: 
2010
Authors: 
M. Ghanim
CRicm INSERM UMRS_975, 75013 Paris, France
Current Affiliation: 
Faculty of Medicine & Health Sciences, Department of Biomedical Sciences, An-Najah National University, Nablus, Palestine
L. Guillot-Noel
CRicm INSERM UMRS_975, 75013 Paris, France
L. Jornea
CRicm INSERM UMRS_975, 75013 Paris, France
B. Dubois
CRicm INSERM UMRS_975, 75013 Paris, France
I. Le Ber
CRicm INSERM UMRS_975, 75013 Paris, France
A. Brice
CRicm INSERM UMRS_975, 75013 Paris, France
F. Pasquier
Department of Neurology and EA2691, University Hospital, Lille, France
V. Deramecourt
Department of Neurology and EA2691, University Hospital, Lille, France
Preferred Abstract (Original): 

Two C-truncating CHMP2B (chromatin modifying protein 2B) mutations were recently found in Danish and Belgian families with autosomal dominant forms of frontotemporal lobar degeneration (FTLD). In addition, few CHMP2B missense mutations of uncertain pathogenic role were reported in several families with FTLD or FTLD associated with motoneuron disease (FTLD-MND). In order to determine the genetic contribution of CHMP2B mutations in FTLD and FTLD-MND families, we analyzed the CHMP2B gene in 198 French probands with familial FTLD and FTLD-MND. One CHMP2B missense variant was found in a proband with familial FTLD (0.8%). The pathogenic role of CHMP2B missense variants is unclear, however the pSer194Leu substitution, located in the C-terminal domain of the protein, was predicted to alter the stability of the protein by in silico analyses. We conclude that CHMP2B mutations represent a rare cause of familial FTLD and they are not implicated in familial FTLD-MND in French patients. The previously reported C-truncating CHMP2B mutations may be private to the Danish and Belgian pedigrees.

Syndicate content